68 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33802010 | Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients. | 2021 Mar 10 | 1 |
2 | 32766764 | Peroxisome proliferator-activated receptor gamma expression along the male genital system and its role in male fertility. | 2020 Sep 1 | 1 |
3 | 33007445 | A paracrine effect of 15 (S)-hydroxyeicosatetraenoic acid revealed in prostaglandin production by human follicular dendritic cell-like cells. | 2020 Dec | 2 |
4 | 29146573 | Prostanoid EP4 agonist L-902,688 activates PPARγ and attenuates pulmonary arterial hypertension. | 2018 Mar 1 | 1 |
5 | 28609844 | An overview on immunoregulatory and anti-inflammatory properties of chrysin and flavonoids substances. | 2017 Aug | 2 |
6 | 26429394 | Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cells. | 2016 Jan | 1 |
7 | 26244663 | Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis. | 2015 | 1 |
8 | 24927844 | Transcriptional regulation in adipogenesis through PPARγ-dependent and -independent mechanisms by prostaglandins. | 2014 | 1 |
9 | 23943857 | Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib. | 2013 Nov | 4 |
10 | 22107041 | In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes. | 2012 Apr | 1 |
11 | 22561694 | Prostaglandin J2 series induces the gene expression of monocyte chemoattractant protein-1 during the maturation phase of cultured adipocytes. | 2012 Jul 10 | 2 |
12 | 22778711 | Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases. | 2012 | 1 |
13 | 23319937 | Prostaglandins as PPARγ Modulators in Adipogenesis. | 2012 | 4 |
14 | 21237281 | Development of enzyme-linked immunosorbent assay for Δ12-prostaglandin J2 and its application to the measurement of the endogenous product generated by cultured adipocytes during the maturation phase. | 2011 Apr | 1 |
15 | 20735405 | Inhibition of monoacylglycerol lipase by troglitazone, N-arachidonoyl dopamine and the irreversible inhibitor JZL184: comparison of two different assays. | 2010 Dec | 1 |
16 | 18203887 | PPARgamma1 as a molecular target of eicosapentaenoic acid in human colon cancer (HT-29) cells. | 2008 Feb | 1 |
17 | 18509496 | Activation and Molecular Targets of Peroxisome Proliferator-Activated Receptor-gamma Ligands in Lung Cancer. | 2008 | 1 |
18 | 18615184 | PPARgamma and Apoptosis in Cancer. | 2008 | 1 |
19 | 17430113 | Pharmacological targeting of IDO-mediated tolerance for treating autoimmune disease. | 2007 Apr | 1 |
20 | 17512458 | Antiinflammatory effects of the cyclopentenone isoprostane 15-A(2)-IsoP in human gestational tissues. | 2007 Jun 15 | 1 |
21 | 17532302 | 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) mediates repression of TNF-alpha by decreasing levels of acetylated histone H3 and H4 at its promoter. | 2007 Jul 20 | 1 |
22 | 17673570 | Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes. | 2007 Nov | 1 |
23 | 16386710 | Niacin induces PPARgamma expression and transcriptional activation in macrophages via HM74 and HM74a-mediated induction of prostaglandin synthesis pathways. | 2006 Feb 28 | 1 |
24 | 16434095 | 15-Deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues. | 2006 Nov-Dec | 1 |
25 | 16454728 | PPAR-gamma agonists as regulators of microglial activation and brain inflammation. | 2006 | 1 |
26 | 16782410 | Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications. | 2006 Jul | 1 |
27 | 16784897 | The role of PPARs in the microvascular dysfunction in diabetes. | 2006 Jul | 1 |
28 | 16842938 | Depot-specific prostaglandin synthesis in human adipose tissue: a novel possible mechanism of adipogenesis. | 2006 Oct 1 | 1 |
29 | 17003477 | Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes. | 2006 Oct | 1 |
30 | 15475569 | Development of nonsteroidal anti-inflammatory drug analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: potential antineoplastic agents that work independently of cyclooxygenase isozymes. | 2005 Jan | 1 |
31 | 15516334 | Epidermal peroxisome proliferator-activated receptor gamma as a target for ultraviolet B radiation. | 2005 Jan 7 | 1 |
32 | 15695504 | Alpha,beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma. | 2005 Apr 8 | 1 |
33 | 15821150 | Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B. | 2005 Jul | 1 |
34 | 15879329 | Increased plasma levels of 15-deoxyDelta prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke. | 2005 Jun | 2 |
35 | 15109566 | Prostanoids and prostanoid receptors in signal transduction. | 2004 Jul | 1 |
36 | 15142970 | Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. | 2004 May 14 | 1 |
37 | 15287152 | Thiazolidinediones increase arachidonic acid release and subsequent prostanoid production in a peroxisome proliferator-activated receptor gamma-independent manner. | 2004 Apr | 2 |
38 | 12707336 | The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms. | 2003 May 1 | 1 |
39 | 12731885 | Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells. | 2003 May 13 | 2 |
40 | 12885795 | PPARgamma inhibition of cyclooxygenase-2, PGE2 synthase, and inducible nitric oxide synthase in cardiac myocytes. | 2003 Oct | 2 |
41 | 12906257 | Role of peroxisome proliferator-activated receptor gamma and its ligands in the control of immune responses. | 2003 | 4 |
42 | 12925148 | Effect of rebamipide on prostaglandin receptors-mediated increase of inflammatory cytokine production by macrophages. | 2003 Jul | 4 |
43 | 11918736 | 15-Deoxy-Delta12,14-prostaglandin J2 regulates mesangial cell proliferation and death. | 2002 Apr | 1 |
44 | 11955950 | Natural ligands of PPARgamma: are prostaglandin J(2) derivatives really playing the part? | 2002 Jul | 5 |
45 | 11987982 | Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists. | 2002 Apr | 1 |
46 | 12064327 | N-3 fatty acids and lipid peroxidation in breast cancer inhibition. | 2002 Mar | 1 |
47 | 12079830 | PPARs: transcription factors controlling lipid and lipoprotein metabolism. | 2002 Jun | 1 |
48 | 12086407 | Prostaglandins and the regulation of tumor growth. | 2002 | 1 |
49 | 12160520 | Regulation of the interleukin-1 receptor antagonist in THP-1 cells by ligands of the peroxisome proliferator-activated receptor gamma. | 2002 Jun 21 | 1 |
50 | 12239635 | The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637. | 2002 Oct | 1 |